Insider / AMGEN INC
MILES AMY E
Director at AMGEN INC
- Company
- AMGEN INC
- First filing on record
- April 17, 2026
- Latest trade on record
- June 30, 2026
- SEC filings
- EDGAR ↗
MILES AMY E, Director at AMGEN INC, has disclosed 4 transactions in GAP, AMGN, CARR since April 17, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $204K at the reported prices. The latest was filed July 1, 2026, 1 day after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months MILES AMY E reported 4 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 4 | 16,381 | $204K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 4 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| GAP | Other A | June 30, 2026 | July 1, 2026 | 1d | 9,903 | — | — | derivative | Form 4 ↗ | |
| GAP | Other A | June 30, 2026 | July 1, 2026 | 1d | 2,329 | — | — | derivative | Form 4 ↗ | |
| AMGN | Other A | May 19, 2026 | May 21, 2026 | 2d | 665 | — | — | Form 4 ↗ | ||
| CARR | Other A | April 15, 2026 | April 17, 2026 | 2d | 3,484 | $59 | $204K | derivative | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 1, 2026 | Form 4 | 0000039911-26-000046 | 2 | published | EDGAR ↗ |
| May 21, 2026 | Form 4 | 0000318154-26-000108 | 1 | published | EDGAR ↗ |
| April 17, 2026 | Form 4 | 0001225208-26-004562 | 1 | published | EDGAR ↗ |
Other insiders at AMGEN INC
- Gruber Julie Chief Legal&Compliance Officer 41 rows
- DICKSON RICHARD President & CEO, Gap Inc. 25 rows
- Grygiel Nancy A. SVP & CCO 21 rows
- O'Connell Katrina Chief Financial Officer 21 rows
- BREWER BRADY ceo, International 20 rows
- Barua Neil President and CEO 18 rows
- Breitbard Mark President & CEO, Gap Brand 18 rows
- FISHER WILLIAM SYDNEY Director 17 rows
- Thompson Amanda J Chief People Officer 17 rows
- Gilligan Sarah Chief Sup Chn & Transform Ofcr 16 rows
Everyone on file, with contracts and lobbying under the company's name: AMGEN INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 4 | April 17, 2026 | July 1, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.